Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers
At five years, 90.9% of proton patients were alive compared to 81% with traditional radiation
Proton therapy also showed benefits in quality of life, such as less feeding tube dependence, less difficulty swallowing, less dry mouth, and higher immune cell counts
Study represents the largest randomized Phase III trial comparing proton to traditional radiation with photons for oropharyngeal cancer patients
HOUSTON, DECEMBER 11, 2025 ― A new study published today in The Lancet showed a significant ...